CellWell record HH-338443
A comparative pharmacokinetic evaluation of two aqueous progesterone 25 mg injections in healthy postmenopausal women under fasting conditions: An open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover bioequivalence study
Noopur Vyas; Amaresh Chakra; Prashant Sarode; Shruti Dharmadhikari; Gaurav Puppalwar; Chintan Khandhedia; Amey Mane; Alpesh Goyani; Ajay Jaysingh Khopade
2026
In plain language
In 48 healthy postmenopausal women, two aqueous progesterone 25 mg injections showed bioequivalent absorption, with exposure ratios of 99%, 99% and 103%, and no serious adverse events were reported.
- Evidence
- Established
- Design
- Randomized controlled trial
Cite this record: https://thecellwell.org/studies/HH-338443
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.